Jacobs Levy Equity Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Sell |
215,633
-2,143
| -1% | -$40.1K | 0.02% | 490 |
|
|
2025
Q1 | $3.92M | Buy |
217,776
+15,687
| +8% | +$282K | 0.02% | 507 |
|
|
2024
Q4 | $3.4M | Buy |
202,089
+24,749
| +14% | +$416K | 0.01% | 497 |
|
|
2024
Q3 | $2.87M | Sell |
177,340
-60,913
| -26% | -$986K | 0.01% | 533 |
|
|
2024
Q2 | $1.96M | Buy |
238,253
+9,294
| +4% | +$76.4K | 0.01% | 600 |
|
|
2024
Q1 | $3.39M | Sell |
228,959
-39,463
| -15% | -$584K | 0.02% | 499 |
|
|
2023
Q4 | $3.89M | Sell |
268,422
-68,486
| -20% | -$993K | 0.02% | 479 |
|
|
2023
Q3 | $3.64M | Sell |
336,908
-20,208
| -6% | -$218K | 0.02% | 439 |
|
|
2023
Q2 | $4.61M | Sell |
357,116
-20,237
| -5% | -$261K | 0.03% | 410 |
|
|
2023
Q1 | $4.98M | Sell |
377,353
-54,894
| -13% | -$725K | 0.03% | 398 |
|
|
2022
Q4 | $6.48M | Buy |
432,247
+136,247
| +46% | +$2.04M | 0.04% | 352 |
|
|
2022
Q3 | $3.49M | Buy |
+296,000
| New | +$3.49M | 0.03% | 459 |
|
|
2020
Q4 | – | Sell |
-4,438
| Closed | -$107K | – | 1081 |
|
|
2020
Q3 | $107K | Sell |
4,438
-136,160
| -97% | -$3.28M | ﹤0.01% | 997 |
|
|
2020
Q2 | $2.57M | Buy |
140,598
+58,720
| +72% | +$1.07M | 0.03% | 474 |
|
|
2020
Q1 | $1.28M | Sell |
81,878
-94,121
| -53% | -$1.47M | 0.02% | 575 |
|
|
2019
Q4 | $3.77M | Buy |
175,999
+92,137
| +110% | +$1.97M | 0.04% | 424 |
|
|
2019
Q3 | $1.57M | Buy |
83,862
+9,569
| +13% | +$179K | 0.02% | 556 |
|
|
2019
Q2 | $1.94M | Buy |
74,293
+9,390
| +14% | +$245K | 0.03% | 528 |
|
|
2019
Q1 | $1.67M | Buy |
+64,903
| New | +$1.67M | 0.02% | 556 |
|
|
2018
Q3 | – | Sell |
-2,850
| Closed | -$81K | – | 1061 |
|
|
2018
Q2 | $81K | Buy |
+2,850
| New | +$81K | ﹤0.01% | 1000 |
|
|
2017
Q4 | – | Sell |
-35,945
| Closed | -$913K | – | 1055 |
|
|
2017
Q3 | $913K | Buy |
35,945
+27,885
| +346% | +$708K | 0.02% | 598 |
|
|
2017
Q2 | $220K | Buy |
+8,060
| New | +$220K | ﹤0.01% | 819 |
|
|
2017
Q1 | – | Sell |
-56,982
| Closed | -$1.36M | – | 986 |
|
|
2016
Q4 | $1.36M | Sell |
56,982
-7,090
| -11% | -$169K | 0.03% | 496 |
|
|
2016
Q3 | $2.35M | Sell |
64,072
-1,880
| -3% | -$69K | 0.04% | 390 |
|
|
2016
Q2 | $1.47M | Sell |
65,952
-5,302
| -7% | -$118K | 0.03% | 487 |
|
|
2016
Q1 | $1.48M | Sell |
71,254
-3,820
| -5% | -$79.5K | 0.03% | 480 |
|
|
2015
Q4 | $2.28M | Sell |
75,074
-1,175
| -2% | -$35.6K | 0.05% | 321 |
|
|
2015
Q3 | $1.88M | Buy |
76,249
+9,700
| +15% | +$240K | 0.04% | 377 |
|
|
2015
Q2 | $2.14M | Buy |
66,549
+30,788
| +86% | +$988K | 0.04% | 368 |
|
|
2015
Q1 | $1.28M | Sell |
35,761
-12,138
| -25% | -$433K | 0.02% | 435 |
|
|
2014
Q4 | $1.09M | Sell |
47,899
-1,893
| -4% | -$43K | 0.02% | 490 |
|
|
2014
Q3 | $966K | Buy |
49,792
+15,447
| +45% | +$300K | 0.02% | 497 |
|
|
2014
Q2 | $1.25M | Sell |
34,345
-2,714
| -7% | -$98.5K | 0.02% | 471 |
|
|
2014
Q1 | $1.44M | Sell |
37,059
-9,563
| -21% | -$371K | 0.02% | 461 |
|
|
2013
Q4 | $1.33M | Buy |
46,622
+33,052
| +244% | +$942K | 0.02% | 505 |
|
|
2013
Q3 | $486K | Sell |
13,570
-10,989
| -45% | -$394K | 0.01% | 699 |
|
|
2013
Q2 | $820K | Buy |
+24,559
| New | +$820K | 0.01% | 615 |
|